Type 1 diabetes mellitus in people with pharmacoresistant epilepsy: Prevalence and clinical characteristics
- 1 September 2015
- journal article
- Published by Elsevier BV in Epilepsy Research
- Vol. 115, 55-57
- https://doi.org/10.1016/j.eplepsyres.2015.05.008
Abstract
No abstract availableKeywords
Funding Information
- Fonds de recherche Québec-santé (Canada)
- Dr Marvin Weil Epilepsy Research Fund
This publication has 14 references indexed in Scilit:
- The somatic comorbidity of epilepsy: A weighty but often unrecognized burdenEpilepsia, 2012
- Association diabète de type 1et épilepsie chez l’enfant. À propos d’une série de 10casArchives de Pédiatrie, 2012
- Clinical significance of glutamic acid decarboxylase antibodies in patients with epilepsyEpilepsia, 2010
- Revised terminology and concepts for organization of seizures and epilepsies: Report of the ILAE Commission on Classification and Terminology, 2005–2009Epilepsia, 2010
- The Burden of Diabetes Mellitus Among US Youth: Prevalence Estimates From the SEARCH for Diabetes in Youth StudyPublished by American Academy of Pediatrics (AAP) ,2006
- An association between type 1 diabetes and idiopathic generalized epilepsyAnnals of Neurology, 2005
- Type 2 and other forms of diabetes in 0-30 year olds: a hospital based study in Leeds, UKArchives of Disease in Childhood, 2003
- Glutamic acid decarboxylase autoantibodies in controlled and uncontrolled epilepsy: a pilot studyEpilepsy Research, 2000
- The clinical significance of an autoimmune response against glutamic acid decarboxylaseNature Medicine, 1996
- Autoantibodies to glutamic acid decarboxylase in palatal myoclonus and epilepsyAnnals of Neurology, 1994